GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCHE, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
14.409 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, AXL, BCHE, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, GSK3B, HSD11B2, HSD17B2, IDO1, IGF1R, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR |
13.6047 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, AXL, BCHE, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, KIT, MMP2, PIK3CA, PPARA, PTGS2, RORC, SRC, TYR |
11.8308 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, AXL, BCHE, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PPARA, PTGS2, RORC, SRC, TERT, TOP1, TYR |
11.5504 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
11.4838 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, BCHE, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, F10, F3, FABP3, FABP4, FLT3, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, KDR, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, SRC, TERT, TNKS, TNKS2, XDH |
10.5725 |
[BP] GO:0033993 |
response to lipid
|
AKR1C3, ALPL, AXL, BCHE, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, IDO1, PTGS2, RORC, SRC, TYR |
10.5725 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCHE, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP2, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
10.5258 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
10.0965 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
10.0965 |
[BP] GO:0014070 |
response to organic cyclic compound
|
AKR1C3, ALPL, APEX1, APP, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, FLT3, HSD11B2, PTGS2, RORC, SRC, TYR |
9.64849 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALPL, APEX1, APP, AURKB, AXL, BCHE, BCL2, CA2, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD11B1, HSD17B2, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TNKS2, TOP2A, TYR |
9.64849 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, BCHE, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, ESR1, ESRRA, F3, FABP3, FLT3, IDO1, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTGS1, PTGS2, SRC, TERT, XDH |
9.41846 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, GSK3B, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
9.36168 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
9.35864 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, F10, F3, FLT3, GSK3B, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
9.35864 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, KIT, MMP2, PPARA, PTGS2, SRC |
9.13646 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
9.07761 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
9.07761 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, NQO2, PTGS1, PTGS2, TYR, XDH |
9.06575 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, AKR1C3, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, KDR, KIT, MMP9, PTGS2, SRC, TERT |
9.06575 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, FUT7, GBA2, GLO1, IDO1, PIK3CA, PIM1, PPARA, PTGS1, PTGS2, TYR, XDH |
9.06575 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCHE, BCL2, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
8.99656 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AKR1C3, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GLO1, GSK3B, IDO1, IGF1R, KDR, MMP9, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TERT, TOP2A, XDH |
8.79086 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, ALPL, APEX1, APP, AURKB, AXL, BCHE, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B2, IDO1, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP1, TOP2A, TYR |
8.74627 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, AKR1C3, ALPL, APEX1, BCHE, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, KIT, PPARA, PTGS2, SRC |
8.68737 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
8.57872 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, AKR1C3, BCL2, CYP1A1, CYP1A2, CYP1B1, TYR |
8.01083 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CSNK2A1, CYP1B1, F10, F3, FLT3, GSK3B, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.98241 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT |
7.79739 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
7.61518 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9, DHFR |
7.46676 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CSNK2A1, CYP1B1, ESRRA, F10, F3, FABP4, FLT3, GSK3B, IDO1, KDR, KIT, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.46299 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC, TERT |
7.40285 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
7.30415 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, BCHE, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
7.21818 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, APP, AXL, BCHE, BCL2, CYP19A1, CYP1A2, CYP1B1, ESR1, ESRRB, F10, F3, FABP4, HSD11B2, HSD17B2, IDO1, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TNKS2, TOP1, TYR |
7.0335 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.876 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, PIK3CA, PTGS2, RORC, SRC |
6.7555 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
6.30354 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, AKR1C3, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, FABP4, FLT3, GSK3B, IGF1R, KDR, KIT, MMP2, MMP9, PIK3CA, PTGS2, PTPN1, RORC, SRC, TERT, TOP2A |
6.21121 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AKR1C3, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, KIT, PIK3CA, PPARA, SRC, TYR |
6.17501 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, AKR1C3, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, KIT, MET, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2 |
6.08551 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, GLO1, GSK3B, IDO1, IGF1R, KDR, MMP9, PIK3CA, PIM1, PTGS2, PTPN1, SRC, TERT |
6.08407 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCHE, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
6.07669 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, APP, AXL, BCL2, CYP1B1, F10, F3, FLT3, KDR, KIT, MET, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
6.02883 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESRRA, ESRRB, FLT3, GBA2, GSK3B, HSD11B1, HSD17B2, KDR, KIT, MMP9, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TYR |
6.02779 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCHE, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.96717 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.96436 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
5.9489 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, AKR1C3, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F3, FLT3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, PTGS2, TERT |
5.91588 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, BCHE, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.91003 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
5.88354 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CDK6, CYP19A1, CYP1B1, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
5.86735 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, AKR1C3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.82803 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TNKS, TOP1, XDH |
5.81067 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.80055 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCHE, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, DHFR, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
5.77511 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AKR1C3, AXL, F10, F3, KIT, MET, PIK3CA, PIK3CB, SRC |
5.75261 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AKR1C3, AXL, F10, F3, KIT, MET, PIK3CA, PIK3CB, SRC, XDH |
5.69535 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
5.66172 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, SRC, TNKS, TOP1 |
5.59956 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, ESR1, GSK3B, KIT, PPARA, RORC, SRC, TOP1, TOP2A |
5.57916 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, AKR1C3, APP, AURKB, BCL2, CDC25B, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.48321 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCHE, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DHFR, FABP3, HSD11B2, KDR, PTGS2, SRC, TOP1 |
5.47974 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, PTGS2, PTPN1, SRC, TNKS, TOP1, XDH |
5.45885 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, AKR1C3, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, PIK3CA, PIK3CB, PTGS1, PTGS2 |
5.34912 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, AKR1C3, APEX1, APP, AXL, CDK6, CYP1B1, ESR1, GSK3B, IGF1R, MMP2, MMP9, PIK3CA, PTGS2, RORC, SRC |
5.34912 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
5.27792 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F10, F3, FLT3, IGF1R, KDR, KIT, MET, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
5.16452 |
[BP] GO:0010038 |
response to metal ion
|
AKR1C3, APP, BCL2, CA2, CYP1A1, CYP1A2, FABP4, KIT, MMP9, PTGS2, TERT |
5.12614 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, GSK3B, IDO1, MMP1, MMP12, MMP2, MMP9, PIK3CB, SRC, XDH |
5.12614 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TNKS, TOP1 |
5.06282 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, PIM1, SRC |
4.91655 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.91655 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, BCL2, CDC25B, CSNK2A1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
4.90556 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, APP, AXL, BCL2, CYP1B1, MMP9, PTGS1, PTGS2, SRC |
4.85047 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TERT |
4.76926 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
AKR1C3, ALPL, APEX1, APP, CYP1A1, CYP1B1, ESR1, FLT3, PTGS2, RORC, SRC |
4.76227 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.76115 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, AKR1C3, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, ESR1, ESRRB, HSD11B2, HSD17B2, IDO1, KIT, MMP2, MMP9, PTGS2, SRC, TOP2A |
4.71536 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.71347 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DHFR, GSK3B, HSD11B2, IDO1, KIT, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PTGS1, PTGS2, PTPN1, SRC, TERT, TOP2A |
4.68671 |
[BP] GO:0031960 |
response to corticosteroid
|
AKR1C3, ALPL, BCHE, BCL2, FLT3, HSD11B2, PTGS2, SRC |
4.60624 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, F10, F3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TERT |
4.60509 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, AKR1C3, ALPL, APP, AXL, BCHE, BCL2, CDC25B, CDK6, CYP1A1, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, KDR, KIT, MET, MMP2, MMP9, PTGS2, RORC, SRC, TERT, TOP2A |
4.60199 |
[BP] GO:0006690 |
icosanoid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
4.59771 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, BCHE, DHFR, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
4.59771 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.59308 |
[BP] GO:0048545 |
response to steroid hormone
|
AKR1C3, ALPL, BCHE, BCL2, CA2, FLT3, HSD11B2, PTGS2, SRC |
4.59308 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, SRC |
4.50645 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.474 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CDK6, KDR, PIK3CB, PTGS2, SRC, TNKS, TNKS2 |
4.44179 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.43329 |
[BP] GO:0032787 |
None
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, GBA2, GLO1, IDO1, PPARA, PTGS1, PTGS2 |
4.40984 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, AKR1C3, CYP19A1, GLO1, IDO1 |
4.38497 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
BCHE, CYP1A1, CYP1A2, CYP1B1, NQO2, PTGS1, RORC |
4.37029 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, AKR1C3, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, ESR2, F10, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
4.34804 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, F10, F3, IGF1R, KDR, KIT, MET, MMP9, PTGS2, SRC, TERT |
4.33717 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AKR1C3, APEX1, AXL, BCL2, CYP1B1, MMP9, SRC |
4.29021 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CDK6, CYP19A1, DHFR, ESR1, F3, FABP4, GSK3B, IDO1, IGF1R, MET, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
4.28484 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, RORC, SRC |
4.27792 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
4.25061 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, BCHE, DHFR, FABP3, FLT3, GSK3B, HSD11B2, IGF1R, MMP2, PPARA, PTGS2, SRC, TYR |
4.24063 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, AKR1C3, BCHE, DHFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
4.24063 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, AKR1C3, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DHFR, GBA2, TYR |
4.17485 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, AKR1C3, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.17189 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, AKR1C3, CYP19A1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.11354 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, AKR1C3, GBA2 |
4.06325 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
4.05984 |
[BP] GO:0006807 |
nitrogen compound metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCHE, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
4.04244 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.03699 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GBA2, GLO1, IDO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
4.02515 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, GSK3B, MET, MMP9, PPARA, SRC, TERT, TNKS |
4.024 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.97069 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GSK3B, HSD11B2, IGF1R, PPARA, PTGS2, SRC |
3.96438 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, AKR1C3, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2 |
3.93613 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, F10, FLT3, GSK3B, IGF1R, KDR, KIT, MET, SRC, TNKS, TOP1, TOP2A |
3.92354 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, AKR1C3, CYP1A1, FABP3, FLT3, KIT, PPARA, PTGS2, RORC, SRC |
3.82114 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, AKR1C3, APEX1, APP, AURKB, BCL2, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, KDR, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.79327 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, BCL2, CDC25B, DHFR, ESR1, ESR2, F3, FLT3, GSK3B, KIT, MET, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TERT, TNKS, XDH |
3.78041 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, ESR1, FABP4, GSK3B, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC, TNKS |
3.76029 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, HSD11B2, MMP2, PPARA, PTGS2, SRC, TERT |
3.68917 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, XDH |
3.68199 |
[BP] GO:0006631 |
fatty acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, FABP3, PPARA, PTGS1, PTGS2 |
3.64446 |
[BP] GO:0040016 |
embryonic cleavage
|
PIK3CB, TOP1, TOP2A |
3.62332 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.60452 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
3.59092 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DHFR, ESR1, F3, FABP4, FLT3, GSK3B, IGF1R, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
3.57667 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
AKR1C3, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2 |
3.56062 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
AKR1C3, APEX1, APP, AURKB, BCL2, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, MET, MMP12, MMP9, PIK3CA, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
3.56062 |
[BP] GO:0043436 |
oxoacid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GBA2, GLO1, IDO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.55837 |
[BP] GO:0046686 |
response to cadmium ion
|
AKR1C3, CYP1A2, KIT, MMP9, TERT |
3.55152 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, ESR1, FABP3, FABP4, FLT3, MET, PIK3CA, PIK3CB, SRC, TERT |
3.5476 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
AKR1C3, ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, KIT, PTGS2, SRC |
3.52777 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, CDK6, GSK3B, KDR, PIK3CB, SRC |
3.50195 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
3.48922 |
[BP] GO:0006082 |
organic acid metabolic process
|
AKR1C3, ALOX5, CYP1A1, CYP1A2, CYP1B1, DHFR, FABP3, GBA2, GLO1, IDO1, PIM1, PPARA, PTGS1, PTGS2, TYR |
3.48361 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
AKR1C3, BCL2, CYP1B1, F3, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH |
3.48324 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.47438 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP3, FLT3, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.47438 |
[BP] GO:0044597 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.47438 |
[BP] GO:0044598 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.47438 |
[BP] GO:0030638 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.47438 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.47438 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
AKR1C3, BCL2, CYP1B1, F3, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH |
3.45832 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.42953 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.41528 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, XDH |
3.38936 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FLT3, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
3.38624 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, BCL2, CDC25B, DHFR, ESR1, F3, FLT3, GSK3B, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TERT, TNKS, XDH |
3.32926 |
[BP] GO:0030647 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
3.3188 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, HSD11B2, KIT, MMP2, PPARA, PTGS2, SRC, TERT, TYR |
3.3188 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AKR1C3, AOX1, BCHE, CYP1A1, CYP1A2, CYP1B1, DHFR, IDO1 |
3.30979 |
[BP] GO:0009991 |
response to extracellular stimulus
|
AKR1C3, ALPL, AXL, BCHE, BCL2, CYP1A1, HSD11B2, PTGS2, SRC, TYR |
3.25897 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, KIT, MET, PIK3CB, PIM1, SRC, TYR |
3.20061 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.1844 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, KIT, MMP9, RORC |
3.17379 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, F3, FABP4, FLT3, GSK3B, IGF1R, KIT, MET, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SRC, TERT, TNKS, XDH |
3.17337 |
[BP] GO:0010942 |
positive regulation of cell death
|
AKR1C3, BCL2, CYP1B1, F3, GSK3B, IDO1, MMP9, PIK3CB, PTGS2, SRC, TOP2A, XDH |
3.16872 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.16484 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PTGS2, SRC |
3.13184 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.12346 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
3.09935 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC |
3.09369 |
[BP] GO:0030154 |
cell differentiation
|
AKR1C3, ALPL, AXL, BCHE, BCL2, CDK6, CYP1A1, ESR1, FABP4, FLT3, FUT7, GLO1, GSK3B, KDR, KIT, MMP2, MMP9, PTGS2, RORC, TOP2A |
3.08768 |
[BP] GO:0048608 |
reproductive structure development
|
AKR1C3, AXL, BCL2, CYP19A1, ESR1, HSD17B2, KIT, SRC |
3.08656 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.07624 |
[BP] GO:0019371 |
None
|
AKR1C3, PTGS1, PTGS2 |
3.07624 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AKR1C3, APEX1, AXL, CYP1B1, MMP9, SRC |
3.06554 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, GSK3B, IDO1, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIM1, PTGS2, SRC, TERT, TNKS2, XDH |
3.06074 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1C3, APEX1, APP, AURKB, AXL, BCHE, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, XDH |
3.06074 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, AKR1C3, APEX1, APP, ESR1, FLT3, GSK3B, IGF1R, KIT, MMP2, PTGS2, SRC |
3.05378 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
3.04825 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TNKS, TNKS2 |
3.02513 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
3.01163 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, FLT3, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.98806 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CDK6, CYP1B1, KDR, PTGS2, SRC |
2.97478 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, BCHE, BCL2, CDK6, CYP1B1, FABP3, IDO1, PTGS2, TERT, XDH |
2.94178 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, AKR1C3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.93875 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, AKR1C3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.89654 |
[BP] GO:0016488 |
None
|
AKR1B10, AKR1C3 |
2.89522 |
[BP] GO:0016487 |
None
|
AKR1B10, AKR1C3 |
2.89522 |
[BP] GO:0016107 |
None
|
AKR1B10, AKR1C3 |
2.89522 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.89522 |
[BP] GO:0006714 |
None
|
AKR1B10, AKR1C3 |
2.89522 |
[BP] GO:0051384 |
response to glucocorticoid
|
ALPL, BCHE, BCL2, FLT3, HSD11B2, PTGS2 |
2.89122 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.88887 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, BCHE, CYP1A1, PTGS2, TYR |
2.88512 |
[BP] GO:0001816 |
cytokine production
|
APP, FABP4, IDO1, KIT, PTGS2 |
2.86119 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.83758 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
2.81556 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BCHE, CA2, CA7, KIT, PTGS2 |
2.81215 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BCHE, CA2, CA7, KIT, PTGS2 |
2.81215 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCHE, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
2.80817 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.80111 |
[BP] GO:0044259 |
multicellular organismal macromolecule metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.79996 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCHE, BCL2, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.77861 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESRRB, FABP3, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, XDH |
2.77861 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, KDR, SRC |
2.76813 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCHE, BCL2, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PTGS2, PTPN1, SRC, TERT, XDH |
2.76697 |
[BP] GO:0071248 |
cellular response to metal ion
|
AKR1C3, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.76423 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AXL, BCL2, CA2, CDK6, CYP1B1, ESR1, ESRRA, ESRRB, F3, GSK3B, IDO1, KDR, KIT, PIK3CA, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TNKS2, XDH |
2.76333 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.76126 |
[BP] GO:0031667 |
response to nutrient levels
|
AKR1C3, ALPL, BCHE, BCL2, CYP1A1, HSD11B2, PTGS2, SRC, TYR |
2.75275 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.72393 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, PIK3CB, PTGS2, TNKS, TNKS2 |
2.71933 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, FABP4, FLT3, GSK3B, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC, TNKS |
2.71602 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F10, F3, FLT3, FUT7, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PPARA, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A |
2.70755 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, CSNK2A1, ESR1, F3, FLT3, GSK3B, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.69449 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA |
2.65706 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, BCL2, ESR1, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.65706 |
[BP] GO:2000811 |
negative regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.64955 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.64955 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC |
2.62337 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, KDR, MET, MMP12, PPARA, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.61565 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CDK6, CYP19A1, ESR1, ESR2, GSK3B, IGF1R, MET, MMP12, MMP9, PPARA, PTGS2, PTPN1, SRC, TERT, XDH |
2.61479 |
[BP] GO:0010906 |
None
|
ESRRB, GSK3B, PPARA, RORC, SRC |
2.60773 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, AKR1C3, BCL2, HSD11B2 |
2.60773 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.6056 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.57744 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CYP1A1, PIM1, TERT, TNKS, TOP2A |
2.56091 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP2A, XDH |
2.54055 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, GSK3B, SRC, TNKS, TOP1 |
2.5368 |
[BP] GO:0006091 |
generation of precursor metabolites and energy
|
AKR1B1, AOX1, CYP19A1, CYP1A2, GSK3B, IDO1, NQO2, XDH |
2.52823 |
[BP] GO:0044283 |
None
|
AKR1B1, AKR1C3, ALOX5, CYP19A1, CYP1A1, DHFR, IDO1, PTGS1, PTGS2 |
2.51857 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.50253 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50253 |
[BP] GO:0016095 |
None
|
AKR1B10, AKR1C3 |
2.50253 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
AKR1C3, BCL2, CYP1B1, DHFR, PTGS2, XDH |
2.4952 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, BCL2, CA2, CDK6, CYP19A1, ESR1, ESRRA, IDO1, KIT, MMP12, MMP2, PIK3CA, PIK3CB, PTPN1, SRC |
2.49051 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, BCL2, CDC25B, ESR1, F3, FLT3, GSK3B, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.48273 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, BCL2, CA2, CYP1B1, ESRRB, F3, IDO1, KDR, KIT, MET, MMP12, MMP9, PIM1, PTGS2, SRC, TERT |
2.47349 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AKR1C3, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, GBA2, GSK3B, IDO1, PIK3CB, SRC, XDH |
2.46847 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, BCL2, CDC25B, FABP4, FLT3, IGF1R, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.46847 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
AKR1C3, CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.46279 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.46132 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.46039 |
[BP] GO:0044242 |
None
|
AKR1B10, AKR1C3, CYP1B1, FABP3, FABP4, GBA2 |
2.45307 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
AKR1C3, MMP1, MMP12, MMP2, MMP9 |
2.44126 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, KDR, KIT, PTGS2, TERT |
2.42811 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.4246 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AKR1C3, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, FABP3, FABP4, FUT7, GBA2, GSK3B, IDO1, XDH |
2.41728 |
[BP] GO:0008406 |
gonad development
|
AKR1C3, BCL2, CYP19A1, ESR1, KIT |
2.40811 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, AKR1C3, ALPL, AXL, BCHE, BCL2, CDK6, CYP1A1, CYP1A2, HSD11B2, IDO1, KIT, MMP12, PTGS2, SRC, TYR |
2.40418 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DHFR, PPARA |
2.38338 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, AKR1C3, APP, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
2.35672 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, AKR1C3, BCHE, CSNK2A1 |
2.3461 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.3449 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.3449 |
[BP] GO:0018209 |
peptidyl-serine modification
|
AURKB, BCL2, GSK3B, SRC, TNKS, TOP1 |
2.32393 |
[BP] GO:1901215 |
negative regulation of neuron death
|
AXL, BCL2, GSK3B, PIK3CA, PPARA, TERT |
2.30068 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.28923 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.28923 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
BCL2, CDK6, GSK3B, KDR, PIK3CB, SRC |
2.28048 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, RORC |
2.28048 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.28048 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.25569 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.25569 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.25569 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25569 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25569 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, MMP12, PPARA, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.25013 |
[BP] GO:2000209 |
regulation of anoikis
|
BCL2, PIK3CA, SRC |
2.24565 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.24565 |
[BP] GO:0007584 |
response to nutrient
|
AKR1C3, ALPL, BCHE, CYP1A1, PTGS2, TYR |
2.2321 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP2, PIK3CA, PIM1, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A |
2.22892 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.22823 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, PTGS2 |
2.21375 |
[BP] GO:0010675 |
None
|
ESRRB, GSK3B, PPARA, RORC, SRC |
2.21375 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.19787 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, BCHE, PTGS2 |
2.19397 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.19397 |
[BP] GO:0010468 |
regulation of gene expression
|
ADORA3, APEX1, APP, AURKB, BCL2, CA9, CDK6, CSNK2A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, GSK3B, KDR, KIT, MET, MMP12, PIK3CA, PIK3CB, PIM1, PPARA, RORC, SRC, TERT, TNKS, TOP1, TOP2A, XDH |
2.17603 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, PIM1, PTGS2, SRC, TERT, TNKS, TOP2A |
2.17603 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.17518 |
[BP] GO:0006081 |
None
|
AKR1B10, AKR1C3, CYP1B1, GLO1 |
2.17518 |
[BP] GO:0051301 |
cell division
|
CDC25B, CDK6, ESRRB, KIT, PIK3CB, TNKS, TOP1, TOP2A |
2.17142 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, APP, AURKB, CSNK2A1, DHFR, ESR1, ESR2, ESRRA, FABP4, GSK3B, IGF1R, KDR, MMP12, MMP9, PPARA, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, XDH |
2.17118 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, AKR1C3, CYP1A1, CYP1A2, CYP1B1 |
2.16465 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC |
2.16465 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, MMP2, PTGS2, SRC |
2.13364 |
[BP] GO:0014910 |
regulation of smooth muscle cell migration
|
APEX1, BCL2, SRC, TERT |
2.13364 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, PIK3CA, TNKS2 |
2.13364 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AURKB, ESR1, ESR2, ESRRA, ESRRB, IGF1R, KDR, MET, MMP12, PPARA, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.12555 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2, TERT |
2.12347 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.12228 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.12228 |
[BP] GO:0006693 |
None
|
AKR1C3, PTGS1, PTGS2 |
2.12228 |
[BP] GO:0006692 |
None
|
AKR1C3, PTGS1, PTGS2 |
2.12228 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, IDO1, PTGS2, SRC |
2.12214 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, FLT3, KDR, KIT, PIK3CB, PTPN1, SRC, XDH |
2.12063 |
[BP] GO:0043281 |
regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
CSNK2A1, F3, MMP9, PTGS2, SRC, XDH |
2.11892 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GSK3B, IGF1R, SRC |
2.1007 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, KDR, SRC |
2.1007 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, ESR1, IGF1R, MET, MMP9, PTGS2, PTPN1, SRC, XDH |
2.09644 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.09644 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.09644 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
AKR1C3, CYP19A1 |
2.09644 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.09644 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.09644 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.09644 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, FABP3, FABP4, KIT, MET, PIK3CA, PIK3CB |
2.09644 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.09434 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GSK3B, IGF1R |
2.09434 |
[BP] GO:1901992 |
positive regulation of mitotic cell cycle phase transition
|
APEX1, APP, CYP1A1, TERT |
2.09354 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
BCL2, MMP9, PTGS2, PTPN1, SRC, TERT |
2.08396 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A |
2.06758 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, ESR1, F10, FLT3, FUT7, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, PTPN1, SRC, TNKS, TNKS2, TOP1, TOP2A |
2.06758 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, BCL2, CDC25B, FLT3, KDR, KIT, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, XDH |
2.06725 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, AKR1C3, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, DHFR, GSK3B, MMP9, PTGS2, PTPN1, SRC, TERT, TOP2A |
2.06725 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, AKR1C3, APEX1, APP, AURKB, BCL2, CA9, CSNK2A1, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GSK3B, IGF1R, KDR, KIT, MET, MMP12, PIM1, PPARA, PTGS2, RORC, SRC, TERT, TNKS, TNKS2, TOP2A |
2.06725 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, BCL2, CSNK2A1, ESRRB, GSK3B, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1 |
2.06725 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, SRC |
2.05604 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, CDK6, DHFR, GSK3B, IGF1R, MET, PTGS2, PTPN1, TERT, XDH |
2.05554 |
[BP] GO:0030198 |
extracellular matrix organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.0499 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, DHFR, FLT3 |
2.04503 |
[BP] GO:0043062 |
extracellular structure organization
|
APP, CYP1B1, KDR, MMP1, MMP12, MMP2, MMP9 |
2.04452 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, ESR1, F3, FABP4, IDO1, KDR, MET, MMP12, PPARA, PTGS2 |
2.04411 |
[BP] GO:0044243 |
multicellular organismal catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.04045 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, IDO1, MMP12, MMP2, PPARA, PTGS2, PTPN1, SRC |
2.02705 |
[BP] GO:0033280 |
response to vitamin D
|
ALPL, PTGS2, TYR |
2.02103 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, FABP4, FLT3, IGF1R, KIT, PIK3CA, PIK3CB, PTPN1, SRC |
2.02071 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, APP, AURKB, BCHE, BCL2, CA1, CA2, CA4, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, KDR, KIT, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
4.68671 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, BCHE |
3.47438 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NQO2, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
3.02852 |
[CC] GO:0009330 |
None
|
TOP1, TOP2A |
2.89522 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCHE, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, F10, FLT3, GBA2, HSD11B1, HSD11B2, HSD17B2, PTGS1, PTGS2, PTPN1 |
2.76126 |
[CC] GO:0043231 |
intracellular membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, APEX1, APP, AURKB, BCL2, CA4, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, IGF1R, KDR, KIT, MMP12, MMP2, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
2.52981 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GLO1, GSK3B, IDO1, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NQO2, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
2.48273 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.40374 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, BCHE, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, F10, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD11B1, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, TYR |
2.18421 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, AKR1C3, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCHE, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, F10, F3, FLT3, FUT7, GBA2, GLO1, GSK3B, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
16.7117 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, AXL, BCHE, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GLO1, GSK3B, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TNKS, TNKS2, TOP1, TOP2A, TYR, XDH |
15.0875 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
14.5474 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
10.0965 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, AKR1C3, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IDO1, NQO2, PTGS1, PTGS2, TYR, XDH |
9.64849 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AURKB, BCHE, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
8.99656 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PTPN1, RORC, TNKS |
8.09263 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, ESR1, ESR2, ESRRA, ESRRB, F10, GLO1, IDO1, KIT, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, TERT, TNKS, TNKS2, TOP2A, TYR, XDH |
7.99273 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.7555 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.21121 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AKR1C3, AOX1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.07608 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, HSD11B2, HSD17B1, IDO1, NQO2, PTGS1, PTGS2, SRC, XDH |
5.96717 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, FLT3, GSK3B, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, SRC, TOP1, TOP2A |
5.56892 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS1, PTGS2, SRC |
5.14006 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.13331 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.13331 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, GLO1 |
5.12614 |
[MF] GO:0005496 |
steroid binding
|
ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, RORC |
5.07531 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, IDO1, PTGS1, PTGS2, SRC |
4.92506 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.92506 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.78273 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
4.71536 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.60624 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, PTGS1, PTGS2, TYR |
4.60624 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIM1, SRC, TOP1 |
4.59761 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, IDO1, NQO2, XDH |
4.50645 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TOP1 |
4.45018 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, AKR1C3, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
4.26317 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.0791 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TOP1 |
4.03487 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AKR1C3, AOX1, XDH |
4.0138 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TERT, TOP1 |
3.87592 |
[MF] GO:0008289 |
lipid binding
|
AXL, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, HSD11B2, HSD17B1, PPARA, RORC |
3.72965 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DHFR, FABP3, FABP4, FLT3, GSK3B, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TOP1, TOP2A, XDH |
3.68199 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.67162 |
[MF] GO:0004497 |
monooxygenase activity
|
AKR1C3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, TYR |
3.67162 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCHE, BCL2, CSNK2A1, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MET, MMP9, NQO2, PTGS2, TERT, TOP2A, TYR, XDH |
3.65623 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, XDH |
3.51945 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
3.48922 |
[MF] GO:0043168 |
anion binding
|
AOX1, APP, AURKB, AXL, CDK6, CSNK2A1, DHFR, F10, F3, FABP3, FABP4, FLT3, GSK3B, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TOP1, TOP2A, XDH |
3.40079 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD11B2, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP1, TOP2A, XDH |
3.22336 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.22336 |
[MF] GO:0000166 |
nucleotide binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TOP1, TOP2A, XDH |
3.1887 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AOX1, AURKB, AXL, CDK6, CSNK2A1, DHFR, FLT3, GSK3B, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, NQO2, PIK3CA, PIK3CB, PIM1, SRC, TOP1, TOP2A, XDH |
3.18749 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DHFR, ESR1, ESR2, ESRRA, ESRRB, FLT3, GSK3B, HSD11B2, HSD17B1, IDO1, IGF1R, KDR, KIT, MET, MMP12, NQO2, PIK3CA, PIK3CB, PIM1, PPARA, PTGS1, PTGS2, PTPN1, RORC, SRC, TERT, TOP1, TOP2A, XDH |
3.17379 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, PIK3CA, PIK3CB |
3.07624 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.89522 |
[MF] GO:0045550 |
None
|
AKR1B10, AKR1C3 |
2.89522 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.89522 |
[MF] GO:0003990 |
acetylcholinesterase activity
|
ACHE, BCHE |
2.89522 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.89522 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.82026 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1 |
2.69442 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CDK6, CSNK2A1, F10, F3, FLT3, GSK3B, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIK3CA, PIM1, PTPN1, SRC, TOP1 |
2.53058 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.51978 |
[MF] GO:0047718 |
None
|
AKR1B10, AKR1C3 |
2.50253 |
[MF] GO:0004104 |
cholinesterase activity
|
ACHE, BCHE |
2.50253 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.40374 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, BCL2, ESR1, ESRRB, FLT3, GSK3B, PIM1, PPARA, SRC, TERT |
2.30679 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25569 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.20995 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TOP1, TOP2A |
2.18845 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.15546 |
[MF] GO:0019899 |
enzyme binding
|
APP, AURKB, BCHE, BCL2, CDC25B, CYP1A1, CYP1A2, ESR1, ESR2, ESRRB, F3, GSK3B, KIT, MET, PPARA, PTGS2, PTPN1, SRC, TNKS2, TOP2A |
2.12254 |
[MF] GO:0004033 |
None
|
AKR1B1, AKR1B10, AKR1C3 |
2.12228 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX5, IDO1, PTGS2 |
2.12228 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TOP1, TOP2A |
2.10128 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.1007 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.09644 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX5, IDO1, PTGS2 |
2.09434 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CDK6, CSNK2A1, FLT3, GSK3B, IGF1R, KDR, KIT, MET, PIK3CA, PIK3CB, PIM1, SRC, TOP1, TOP2A |
2.08758 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, IGF1R, KDR, KIT, MET, PPARA, RORC |
2.04503 |
[MF] GO:0035004 |
phosphatidylinositol 3-kinase activity
|
KIT, MET, PIK3CA, PIK3CB |
2.02079 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, AOX1, BCL2, FLT3, KIT, NQO2, PTGS2, TERT, TOP2A, TYR, XDH |
2.00275 |